[Ip-health] Dept of State cables on Brazil compulsory licenses, Jan 04 to May 06

[James Love]

Thanks to David Serafino for typing up these interesting US Department
of State cables about Brazil compulsory licenses, obtained by Michael
Palmedo in a 2006 FOIA request.   The dates are from January 30, 2004 to
May 11, 2006, and mostly focus on negotiations over prices and possible
compulsory licenses on patents.   They will be instructive for students
and journalists seeking to better understand US foreign policy on
pharmaceutical issues.

 Jamie


http://www.keionline.org/index.php?option=3Dcom_content&task=3Dview&id=3D13=
4

U.S. State Department Cables on Brazil Patent Policy

The following are selected cables from the US Department of State,
obtained under the U.S. FOIA statutes, concerning patents  and price
negotiations on AIDS drugs.

U.S. DoS Cable: GOB REACHES PRICING AGREEMENTS ON THREE MORE AIDS DRUGS
- January 30, 2004

U.S. DoS Cable: U.S. PHARMA FIRMS THREATENED WITH LICENSING - June 3,
2005

U.S. DoS Cable: BRAZIL GIVES ABBOTT TEN DAYS BEFORE BREAKING PATENT -
June 28, 2005

U.S. DoS Cable: OFFICIAL INFORMAL REGIONAL ECONOMIC POLICY AND SUMMIT
REVIEW - July 7, 2005

U.S. DoS Cable: SOUTH AMERICA ESTH NEWS, NUMBER 58 - July 8, 2005

U.S. DoS Cable: REGIONAL ECONOMIC POLICY AND SUMMIT REVIEW =E2=80=93 July 1=
5,
2005

U.S. DoS Cable: REGIONAL ECONOMIC POLICY AND SUMMIT REVIEW - August 2,
2005

U.S. DoS Cable: Brazil=E2=80=99s National Health Council Recommends Compuls=
ory
Licensing - August 12, 2005

U.S. DoS Cable: BRAZILIAN MOH SLOWS PACE ON COMPULSORY LICENSING -
September 5, 2005

U.S. DoS Cable: ABBOTT AND GOB REACH DEAL TO AVOID COMPULSORY LICENSE -
October 13, 2005

U.S. DoS Cable: INTERFARMA BRIEFS CHARGE - February 7, 2006

U.S. DoS Cable: BRAZIL=E2=80=99S MINISTER OF HEALTH REPONDS POSITIVELY - Ma=
y 11,
2006
--
_____________________________
James Love, Knowledge Ecology International (KEI)
http://www.keionline.org, mailto:james.love@keionline.org
voice +1.202.332.2670, fax +1.202.332.2673, mobile +1.202.361.3040